BillionToOne, Inc.
Nasdaq · Services-Medical Laboratories
Company Overview
A concise company profile alongside the latest public filing activity.
BillionToOne develops molecular diagnostic tests, including non-invasive prenatal screening and cancer-related liquid biopsy tests, using its molecular counting technology to detect and quantify DNA molecules from blood samples.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| Lynch Thomas P.See Remarks | Sell | $2.14M | 19,384at $110.36 | Sep 17, 2026 |
| Lynch Thomas P.See Remarks | Sell | $769K | 6,968at $110.30 | Sep 17, 2026 |
| Lynch Thomas P.See Remarks | Sell | $644K | 5,840at $110.29 | Sep 17, 2026 |
| Lynch Thomas P.See Remarks | Sell | $322K | 2,920at $110.31 | Sep 17, 2026 |
| Lynch Thomas P.See Remarks | Sell | $113K | 1,131at $100.33 | Sep 8, 2026 |
| Lynch Thomas P.See Remarks | Sell | $78K | 775at $100.83 | Sep 8, 2026 |
| Lynch Thomas P.See Remarks | Sell | $61K | 614at $99.00 | Sep 8, 2026 |
| Lynch Thomas P.See Remarks | Sell | $57K | 576at $98.89 | Sep 8, 2026 |
| Lynch Thomas P.See Remarks | Sell | $830K | 8,285at $100.12 | Sep 8, 2026 |
| Lynch Thomas P.See Remarks | Sell | $36K | 358at $100.82 | Sep 8, 2026 |
| Lynch Thomas P.See Remarks | Sell | $23K | 232at $100.92 | Sep 8, 2026 |
| Lynch Thomas P.See Remarks | Sell | $15K | 147at $101.41 | Sep 8, 2026 |
| Lynch Thomas P.See Remarks | Sell | $4K | 38at $96.47 | Sep 8, 2026 |
| Lynch Thomas P.See Remarks | Sell | $38K | 385at $99.22 | Sep 8, 2026 |
| Lynch Thomas P.See Remarks | Sell | $300K | 2,997at $100.11 | Sep 8, 2026 |
| Lynch Thomas P.See Remarks | Sell | $252K | 2,518at $100.20 | Sep 8, 2026 |
| Lynch Thomas P.See Remarks | Sell | $192K | 1,944at $98.97 | Sep 8, 2026 |
| Atay OguzhanChairman and CEO | Sell | $11K | 84at $133.01 | Aug 3, 2026 |
| Atay OguzhanChairman and CEO | Sell | $11K | 84at $133.00 | Aug 3, 2026 |
| Atay OguzhanChairman and CEO | Sell | $1.37M | 9,989at $137.25 | Aug 3, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable BLLN activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.